SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2vob'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AV2_A_DVAA6_0 (GRAMICIDIN A)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	3 / 3	ALA A 32 VAL A 30 TRP A 66	None	0.97A	1av2A-2vobA: undetectable 1av2B-2vobA: undetectable	1av2A-2vobA: 3.50 1av2B-2vobA: 3.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_C_DVAC6_0 (GRAMICIDIN A)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	3 / 3	ALA A 347 VAL A 508 TRP A 460	None	0.93A	1c4dC-2vobA: undetectable 1c4dD-2vobA: undetectable	1c4dC-2vobA: 3.50 1c4dD-2vobA: 3.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HWI_A_115A2_2 (HMG-COA REDUCTASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	HIS A 211 LEU A 206 ALA A 93 LEU A 74	None	1.01A	1hwiB-2vobA: undetectable	1hwiB-2vobA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HWI_D_115D3_1 (HMG-COA REDUCTASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	HIS A 211 LEU A 206 ALA A 93 LEU A 74	None	1.01A	1hwiC-2vobA: undetectable	1hwiC-2vobA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	3 / 3	TRP A 506 HIS A 284 MET A 288	None	1.09A	1l5qB-2vobA: undetectable	1l5qB-2vobA: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MRG_A_ADNA300_1 (ALPHA-MOMORCHARIN)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 9	ILE A 598 PHE A 272 ILE A 612 ALA A 596 GLU A 614	None	1.33A	1mrgA-2vobA: undetectable	1mrgA-2vobA: 18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QZR_B_CDXB901_1 (DNA TOPOISOMERASE II)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	THR A 411 TYR A 410 LEU A 244 GLN A 409	None	1.07A	1qzrA-2vobA: undetectable	1qzrA-2vobA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QZR_B_CDXB901_2 (DNA TOPOISOMERASE II)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	THR A 411 TYR A 410 LEU A 244 GLN A 409	None	1.07A	1qzrB-2vobA: undetectable	1qzrB-2vobA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RH3_A_MTXA161_1 (DIHYDROFOLATE REDUCTASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	ILE A 515 SER A 317 ILE A 314 ARG A 315 LEU A 301	None	1.32A	1rh3A-2vobA: undetectable	1rh3A-2vobA: 13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SBR_B_VIBB504_1 (YKOF)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 6	PRO A 527 HIS A 526 PHE A 19 SER A 42	None	1.23A	1sbrA-2vobA: undetectable 1sbrB-2vobA: undetectable	1sbrA-2vobA: 14.57 1sbrB-2vobA: 14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.84A	1v55C-2vobA: undetectable 1v55N-2vobA: undetectable 1v55P-2vobA: undetectable	1v55C-2vobA: 15.17 1v55N-2vobA: 21.23 1v55P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W5U_A_DVAA6_0 (GRAMICIDIN D)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	3 / 3	ALA A 32 VAL A 30 TRP A 66	None	0.93A	1w5uA-2vobA: undetectable 1w5uB-2vobA: undetectable	1w5uA-2vobA: 3.50 1w5uB-2vobA: 3.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_2_BO221405_1 (PROTEASOME COMPONENT PRE3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 11	THR A 610 ALA A 606 SER A 377 GLY A 378 ALA A 380	None	1.18A	2f162-2vobA: undetectable	2f162-2vobA: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 11	THR A 610 ALA A 606 SER A 377 GLY A 378 ALA A 380	None	1.18A	2f16N-2vobA: undetectable	2f16N-2vobA: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IZQ_D_DVAD6_0 (GRAMICIDIN D)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	3 / 3	TRP A 66 ALA A 32 VAL A 30	None	0.94A	2izqC-2vobA: undetectable 2izqD-2vobA: undetectable	2izqC-2vobA: 3.50 2izqD-2vobA: 3.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_N_CHDN1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.93A	2y69C-2vobA: undetectable 2y69N-2vobA: undetectable 2y69P-2vobA: undetectable	2y69C-2vobA: 15.17 2y69N-2vobA: 21.23 2y69P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.85A	3ablA-2vobA: undetectable 3ablC-2vobA: undetectable 3ablP-2vobA: undetectable	3ablA-2vobA: 21.23 3ablC-2vobA: 15.17 3ablP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.88A	3ablC-2vobA: undetectable 3ablN-2vobA: undetectable 3ablP-2vobA: undetectable	3ablC-2vobA: 15.17 3ablN-2vobA: 21.23 3ablP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.88A	3abmA-2vobA: undetectable 3abmC-2vobA: undetectable 3abmP-2vobA: undetectable	3abmA-2vobA: 21.23 3abmC-2vobA: 15.17 3abmP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.86A	3asnC-2vobA: undetectable 3asnN-2vobA: undetectable 3asnP-2vobA: undetectable	3asnC-2vobA: 15.17 3asnN-2vobA: 21.23 3asnP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.89A	3asoA-2vobA: undetectable 3asoC-2vobA: undetectable 3asoP-2vobA: undetectable	3asoA-2vobA: 21.23 3asoC-2vobA: 15.17 3asoP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.90A	3asoC-2vobA: undetectable 3asoN-2vobA: undetectable 3asoP-2vobA: undetectable	3asoC-2vobA: 15.17 3asoN-2vobA: 21.23 3asoP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AX9_B_SALB1340_1 (XANTHINE DEHYDROGENASE/OXIDAS E)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 220 SER A 268 ALA A 627 ALA A 628	None	1.02A	3ax9B-2vobA: undetectable	3ax9B-2vobA: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3I5U_B_SAMB401_0 (O-METHYLTRANSFERASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	LEU A 220 GLY A 599 GLY A 611 SER A 351 ALA A 596	None	1.12A	3i5uB-2vobA: 2.7	3i5uB-2vobA: 19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ID6_C_SAMC301_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	TYR A 25 GLY A 24 SER A 34 ASP A 146 ALA A 145	None	1.20A	3id6C-2vobA: undetectable	3id6C-2vobA: 15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_2_BO221405_1 (PROTEASOME COMPONENT PRE3 PROTEASOME COMPONENT PUP1)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	THR A 610 ALA A 606 SER A 377 GLY A 378 ALA A 380	None	1.12A	3mg02-2vobA: undetectable 3mg0V-2vobA: undetectable	3mg02-2vobA: 16.07 3mg0V-2vobA: 16.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 11	THR A 610 ALA A 606 SER A 377 GLY A 378 ALA A 380	None	1.14A	3mg0N-2vobA: undetectable	3mg0N-2vobA: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TAJ_A_NBOA700_1 (LACTOTRANSFERRIN)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 7	GLY A 129 ASN A 126 TYR A 149 GLY A 132 THR A 133	None	1.47A	3tajA-2vobA: undetectable	3tajA-2vobA: 20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VNS_A_DVAA602_0 (NRPS ADENYLATION PROTEIN CYTC1)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	PHE A 331 PHE A 329 GLY A 280 THR A 610	None	0.91A	3vnsA-2vobA: 3.4	3vnsA-2vobA: 23.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.92A	3wg7A-2vobA: undetectable 3wg7C-2vobA: undetectable 3wg7P-2vobA: undetectable	3wg7A-2vobA: 21.23 3wg7C-2vobA: 15.17 3wg7P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.92A	3wg7C-2vobA: undetectable 3wg7N-2vobA: undetectable 3wg7P-2vobA: undetectable	3wg7C-2vobA: 15.17 3wg7N-2vobA: 21.23 3wg7P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.88A	3x2qA-2vobA: undetectable 3x2qC-2vobA: undetectable 3x2qP-2vobA: undetectable	3x2qA-2vobA: 21.23 3x2qC-2vobA: 15.17 3x2qP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_P_CHDP308_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.91A	3x2qC-2vobA: undetectable 3x2qN-2vobA: undetectable 3x2qP-2vobA: undetectable	3x2qC-2vobA: 15.17 3x2qN-2vobA: 21.23 3x2qP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_A_LDPA501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 6	PHE A 586 ALA A 332 ALA A 528 PRO A 527	None	0.99A	4dtzA-2vobA: undetectable	4dtzA-2vobA: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EK1_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 6	TYR A 120 LEU A 162 VAL A 142 ASP A 146	None	1.09A	4ek1A-2vobA: undetectable	4ek1A-2vobA: 22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IB4_A_ERMA2001_1 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	LEU A 274 VAL A 277 ALA A 606 PHE A 379 VAL A 128	None	1.22A	4ib4A-2vobA: undetectable	4ib4A-2vobA: 20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YP2_B_NCAB302_0 (RIBOSOME-INACTIVATIN G PROTEIN MOMORDIN I)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 9	ILE A 598 PHE A 272 ILE A 612 ALA A 596 GLU A 614	None	1.29A	4yp2B-2vobA: undetectable	4yp2B-2vobA: 16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.91A	5b1aA-2vobA: undetectable 5b1aC-2vobA: undetectable 5b1aP-2vobA: undetectable	5b1aA-2vobA: 21.23 5b1aC-2vobA: 15.17 5b1aP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.87A	5b1bA-2vobA: undetectable 5b1bC-2vobA: undetectable 5b1bP-2vobA: undetectable	5b1bA-2vobA: 21.23 5b1bC-2vobA: 15.17 5b1bP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.90A	5b3sA-2vobA: undetectable 5b3sC-2vobA: undetectable 5b3sP-2vobA: undetectable	5b3sA-2vobA: 21.23 5b3sC-2vobA: 15.17 5b3sP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CF9_B_NCAB302_0 (RIBOSOME-INACTIVATIN G PROTEIN MOMORDIN I)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 9	ILE A 598 PHE A 272 ILE A 612 ALA A 596 GLU A 614	None	1.30A	5cf9B-2vobA: undetectable	5cf9B-2vobA: 16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.85A	5iy5C-2vobA: undetectable 5iy5N-2vobA: undetectable 5iy5P-2vobA: undetectable	5iy5C-2vobA: 15.22 5iy5N-2vobA: 21.23 5iy5P-2vobA: 15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VEU_A_RITA602_1 (CYTOCHROME P450 3A5)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	5 / 12	LEU A 516 PHE A 287 ILE A 529 ALA A 332 GLY A 599	None	0.79A	5veuA-2vobA: undetectable	5veuA-2vobA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_B_CVIB301_1 (REGULATORY PROTEIN TETR)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	GLY A 426 GLN A 321 TRP A 389 ASP A 445	None	1.01A	5vlmB-2vobA: undetectable	5vlmB-2vobA: 16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W97_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.90A	5w97A-2vobA: undetectable 5w97C-2vobA: undetectable 5w97c-2vobA: undetectable	5w97A-2vobA: 21.23 5w97C-2vobA: 15.17 5w97c-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W97_C_CHDC302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.93A	5w97C-2vobA: undetectable 5w97a-2vobA: undetectable 5w97c-2vobA: undetectable	5w97C-2vobA: 15.17 5w97a-2vobA: 21.23 5w97c-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.88A	5wauA-2vobA: undetectable 5wauC-2vobA: undetectable 5wauc-2vobA: undetectable	5wauA-2vobA: 21.23 5wauC-2vobA: 15.17 5wauc-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.85A	5wauC-2vobA: undetectable 5waua-2vobA: undetectable 5wauc-2vobA: undetectable	5wauC-2vobA: 15.17 5waua-2vobA: 21.23 5wauc-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WYQ_A_SAMA401_1 (TRNA (GUANINE-N(1)-)-METH YLTRANSFERASE)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 4	ASP A 447 SER A 446 ASP A 445 HIS A 399	None	0.90A	5wyqB-2vobA: 0.0	5wyqB-2vobA: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.91A	5x19A-2vobA: undetectable 5x19C-2vobA: undetectable 5x19P-2vobA: undetectable	5x19A-2vobA: 21.23 5x19C-2vobA: 15.17 5x19P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.88A	5x1bA-2vobA: undetectable 5x1bC-2vobA: undetectable 5x1bP-2vobA: undetectable	5x1bA-2vobA: 21.23 5x1bC-2vobA: 15.17 5x1bP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.87A	5x1fA-2vobA: undetectable 5x1fC-2vobA: undetectable 5x1fP-2vobA: undetectable	5x1fA-2vobA: 21.23 5x1fC-2vobA: 15.17 5x1fP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.89A	5xdqA-2vobA: undetectable 5xdqC-2vobA: undetectable 5xdqP-2vobA: undetectable	5xdqA-2vobA: 21.23 5xdqC-2vobA: 15.17 5xdqP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.87A	5xdqC-2vobA: undetectable 5xdqN-2vobA: undetectable 5xdqP-2vobA: undetectable	5xdqC-2vobA: 15.17 5xdqN-2vobA: 21.23 5xdqP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.87A	5xdxC-2vobA: undetectable 5xdxN-2vobA: undetectable 5xdxP-2vobA: undetectable	5xdxC-2vobA: 14.87 5xdxN-2vobA: 21.23 5xdxP-2vobA: 14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.92A	5z84A-2vobA: undetectable 5z84C-2vobA: undetectable 5z84P-2vobA: undetectable	5z84A-2vobA: 21.23 5z84C-2vobA: 15.17 5z84P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.90A	5z84C-2vobA: undetectable 5z84N-2vobA: undetectable 5z84P-2vobA: undetectable	5z84C-2vobA: 15.17 5z84N-2vobA: 21.23 5z84P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.93A	5z85A-2vobA: undetectable 5z85C-2vobA: undetectable 5z85P-2vobA: undetectable	5z85A-2vobA: 21.23 5z85C-2vobA: 15.17 5z85P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.89A	5z85C-2vobA: undetectable 5z85N-2vobA: undetectable 5z85P-2vobA: undetectable	5z85C-2vobA: 15.17 5z85N-2vobA: 21.23 5z85P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.90A	5z86A-2vobA: undetectable 5z86C-2vobA: undetectable 5z86P-2vobA: undetectable	5z86A-2vobA: 21.23 5z86C-2vobA: 15.17 5z86P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.91A	5z86C-2vobA: undetectable 5z86N-2vobA: undetectable 5z86P-2vobA: undetectable	5z86C-2vobA: 15.17 5z86N-2vobA: 21.23 5z86P-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.92A	5zcoA-2vobA: undetectable 5zcoC-2vobA: undetectable 5zcoP-2vobA: undetectable	5zcoA-2vobA: 21.23 5zcoC-2vobA: 15.17 5zcoP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.90A	5zcoC-2vobA: undetectable 5zcoN-2vobA: undetectable 5zcoP-2vobA: undetectable	5zcoC-2vobA: 15.17 5zcoN-2vobA: 21.23 5zcoP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.96A	5zcpA-2vobA: undetectable 5zcpC-2vobA: undetectable 5zcpP-2vobA: undetectable	5zcpA-2vobA: 21.23 5zcpC-2vobA: 15.17 5zcpP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.94A	5zcpC-2vobA: undetectable 5zcpN-2vobA: undetectable 5zcpP-2vobA: undetectable	5zcpC-2vobA: 15.17 5zcpN-2vobA: 21.23 5zcpP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.91A	5zcqA-2vobA: undetectable 5zcqC-2vobA: undetectable 5zcqP-2vobA: undetectable	5zcqA-2vobA: 21.23 5zcqC-2vobA: 15.17 5zcqP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 8	LEU A 493 ASP A 466 THR A 465 TYR A 468	None	0.91A	6nknC-2vobA: undetectable 6nknN-2vobA: undetectable 6nknP-2vobA: undetectable	6nknC-2vobA: 15.17 6nknN-2vobA: 21.23 6nknP-2vobA: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	2vob	TRYPANOTHIONE SYNTHETASE (Leishmania major)	4 / 7	ASP A 466 THR A 465 TYR A 468 LEU A 493	None	0.92A	6nmfA-2vobA: undetectable 6nmfC-2vobA: undetectable 6nmfP-2vobA: undetectable	6nmfA-2vobA: 21.23 6nmfC-2vobA: 15.17 6nmfP-2vobA: 15.17

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AV2_A_DVAA6_0","GRAMICIDIN A","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",3,"ALA A  32;VAL A  30;TRP A  66","None","0.97A","1av2A-2vobA:undetectable;1av2B-2vobA:undetectable","1av2A-2vobA:3.50;1av2B-2vobA:3.50"],["1C4D_C_DVAC6_0","GRAMICIDIN A","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",3,"ALA A 347;VAL A 508;TRP A 460","None","0.93A","1c4dC-2vobA:undetectable;1c4dD-2vobA:undetectable","1c4dC-2vobA:3.50;1c4dD-2vobA:3.50"],["1HWI_A_115A2_2","HMG-COA REDUCTASE;HMG-COA REDUCTASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"HIS A 211;LEU A 206;ALA A  93;LEU A  74","None","1.01A","1hwiB-2vobA:undetectable","1hwiB-2vobA:22.06"],["1HWI_D_115D3_1","HMG-COA REDUCTASE;HMG-COA REDUCTASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"HIS A 211;LEU A 206;ALA A  93;LEU A  74","None","1.01A","1hwiC-2vobA:undetectable","1hwiC-2vobA:22.06"],["1L5Q_B_CFFB1864_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",3,"TRP A 506;HIS A 284;MET A 288","None","1.09A","1l5qB-2vobA:undetectable","1l5qB-2vobA:22.01"],["1MRG_A_ADNA300_1","ALPHA-MOMORCHARIN","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"ILE A 598;PHE A 272;ILE A 612;ALA A 596;GLU A 614","None","1.33A","1mrgA-2vobA:undetectable","1mrgA-2vobA:18.30"],["1QZR_B_CDXB901_1","DNA TOPOISOMERASE II;DNA TOPOISOMERASE II","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"THR A 411;TYR A 410;LEU A 244;GLN A 409","None","1.07A","1qzrA-2vobA:undetectable","1qzrA-2vobA:19.51"],["1QZR_B_CDXB901_2","DNA TOPOISOMERASE II","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"THR A 411;TYR A 410;LEU A 244;GLN A 409","None","1.07A","1qzrB-2vobA:undetectable","1qzrB-2vobA:19.51"],["1RH3_A_MTXA161_1","DIHYDROFOLATE REDUCTASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"ILE A 515;SER A 317;ILE A 314;ARG A 315;LEU A 301","None","1.32A","1rh3A-2vobA:undetectable","1rh3A-2vobA:13.65"],["1SBR_B_VIBB504_1","YKOF;YKOF","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"PRO A 527;HIS A 526;PHE A  19;SER A  42","None","1.23A","1sbrA-2vobA:undetectable;1sbrB-2vobA:undetectable","1sbrA-2vobA:14.57;1sbrB-2vobA:14.57"],["1V55_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.84A","1v55C-2vobA:undetectable;1v55N-2vobA:undetectable;1v55P-2vobA:undetectable","1v55C-2vobA:15.17;1v55N-2vobA:21.23;1v55P-2vobA:15.17"],["1W5U_A_DVAA6_0","GRAMICIDIN D","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",3,"ALA A  32;VAL A  30;TRP A  66","None","0.93A","1w5uA-2vobA:undetectable;1w5uB-2vobA:undetectable","1w5uA-2vobA:3.50;1w5uB-2vobA:3.50"],["2F16_2_BO221405_1","PROTEASOME COMPONENT PRE3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"THR A 610;ALA A 606;SER A 377;GLY A 378;ALA A 380","None","1.18A","2f162-2vobA:undetectable","2f162-2vobA:16.07"],["2F16_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"THR A 610;ALA A 606;SER A 377;GLY A 378;ALA A 380","None","1.18A","2f16N-2vobA:undetectable","2f16N-2vobA:16.07"],["2IZQ_D_DVAD6_0","GRAMICIDIN D","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",3,"TRP A  66;ALA A  32;VAL A  30","None","0.94A","2izqC-2vobA:undetectable;2izqD-2vobA:undetectable","2izqC-2vobA:3.50;2izqD-2vobA:3.50"],["2Y69_N_CHDN1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.93A","2y69C-2vobA:undetectable;2y69N-2vobA:undetectable;2y69P-2vobA:undetectable","2y69C-2vobA:15.17;2y69N-2vobA:21.23;2y69P-2vobA:15.17"],["3ABL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.85A","3ablA-2vobA:undetectable;3ablC-2vobA:undetectable;3ablP-2vobA:undetectable","3ablA-2vobA:21.23;3ablC-2vobA:15.17;3ablP-2vobA:15.17"],["3ABL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.88A","3ablC-2vobA:undetectable;3ablN-2vobA:undetectable;3ablP-2vobA:undetectable","3ablC-2vobA:15.17;3ablN-2vobA:21.23;3ablP-2vobA:15.17"],["3ABM_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.88A","3abmA-2vobA:undetectable;3abmC-2vobA:undetectable;3abmP-2vobA:undetectable","3abmA-2vobA:21.23;3abmC-2vobA:15.17;3abmP-2vobA:15.17"],["3ASN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.86A","3asnC-2vobA:undetectable;3asnN-2vobA:undetectable;3asnP-2vobA:undetectable","3asnC-2vobA:15.17;3asnN-2vobA:21.23;3asnP-2vobA:15.17"],["3ASO_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.89A","3asoA-2vobA:undetectable;3asoC-2vobA:undetectable;3asoP-2vobA:undetectable","3asoA-2vobA:21.23;3asoC-2vobA:15.17;3asoP-2vobA:15.17"],["3ASO_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.90A","3asoC-2vobA:undetectable;3asoN-2vobA:undetectable;3asoP-2vobA:undetectable","3asoC-2vobA:15.17;3asoN-2vobA:21.23;3asoP-2vobA:15.17"],["3AX9_B_SALB1340_1","XANTHINE DEHYDROGENASE\/OXIDASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 220;SER A 268;ALA A 627;ALA A 628","None","1.02A","3ax9B-2vobA:undetectable","3ax9B-2vobA:19.32"],["3I5U_B_SAMB401_0","O-METHYLTRANSFERASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"LEU A 220;GLY A 599;GLY A 611;SER A 351;ALA A 596","None","1.12A","3i5uB-2vobA:2.7","3i5uB-2vobA:19.97"],["3ID6_C_SAMC301_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"TYR A  25;GLY A  24;SER A  34;ASP A 146;ALA A 145","None","1.20A","3id6C-2vobA:undetectable","3id6C-2vobA:15.01"],["3MG0_2_BO221405_1","PROTEASOME COMPONENT PRE3;PROTEASOME COMPONENT PUP1","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"THR A 610;ALA A 606;SER A 377;GLY A 378;ALA A 380","None","1.12A","3mg02-2vobA:undetectable;3mg0V-2vobA:undetectable","3mg02-2vobA:16.07;3mg0V-2vobA:16.89"],["3MG0_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"THR A 610;ALA A 606;SER A 377;GLY A 378;ALA A 380","None","1.14A","3mg0N-2vobA:undetectable","3mg0N-2vobA:16.07"],["3TAJ_A_NBOA700_1","LACTOTRANSFERRIN","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"GLY A 129;ASN A 126;TYR A 149;GLY A 132;THR A 133","None","1.47A","3tajA-2vobA:undetectable","3tajA-2vobA:20.12"],["3VNS_A_DVAA602_0","NRPS ADENYLATION PROTEIN CYTC1","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"PHE A 331;PHE A 329;GLY A 280;THR A 610","None","0.91A","3vnsA-2vobA:3.4","3vnsA-2vobA:23.49"],["3WG7_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.92A","3wg7A-2vobA:undetectable;3wg7C-2vobA:undetectable;3wg7P-2vobA:undetectable","3wg7A-2vobA:21.23;3wg7C-2vobA:15.17;3wg7P-2vobA:15.17"],["3WG7_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.92A","3wg7C-2vobA:undetectable;3wg7N-2vobA:undetectable;3wg7P-2vobA:undetectable","3wg7C-2vobA:15.17;3wg7N-2vobA:21.23;3wg7P-2vobA:15.17"],["3X2Q_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.88A","3x2qA-2vobA:undetectable;3x2qC-2vobA:undetectable;3x2qP-2vobA:undetectable","3x2qA-2vobA:21.23;3x2qC-2vobA:15.17;3x2qP-2vobA:15.17"],["3X2Q_P_CHDP308_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.91A","3x2qC-2vobA:undetectable;3x2qN-2vobA:undetectable;3x2qP-2vobA:undetectable","3x2qC-2vobA:15.17;3x2qN-2vobA:21.23;3x2qP-2vobA:15.17"],["4DTZ_A_LDPA501_1","CYTOCHROME P450 BM3 VARIANT 8C8","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"PHE A 586;ALA A 332;ALA A 528;PRO A 527","None","0.99A","4dtzA-2vobA:undetectable","4dtzA-2vobA:21.35"],["4EK1_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"TYR A 120;LEU A 162;VAL A 142;ASP A 146","None","1.09A","4ek1A-2vobA:undetectable","4ek1A-2vobA:22.49"],["4IB4_A_ERMA2001_1","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"LEU A 274;VAL A 277;ALA A 606;PHE A 379;VAL A 128","None","1.22A","4ib4A-2vobA:undetectable","4ib4A-2vobA:20.15"],["4YP2_B_NCAB302_0","RIBOSOME-INACTIVATING PROTEIN MOMORDIN I","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"ILE A 598;PHE A 272;ILE A 612;ALA A 596;GLU A 614","None","1.29A","4yp2B-2vobA:undetectable","4yp2B-2vobA:16.24"],["5B1A_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.91A","5b1aA-2vobA:undetectable;5b1aC-2vobA:undetectable;5b1aP-2vobA:undetectable","5b1aA-2vobA:21.23;5b1aC-2vobA:15.17;5b1aP-2vobA:15.17"],["5B1B_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.87A","5b1bA-2vobA:undetectable;5b1bC-2vobA:undetectable;5b1bP-2vobA:undetectable","5b1bA-2vobA:21.23;5b1bC-2vobA:15.17;5b1bP-2vobA:15.17"],["5B3S_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.90A","5b3sA-2vobA:undetectable;5b3sC-2vobA:undetectable;5b3sP-2vobA:undetectable","5b3sA-2vobA:21.23;5b3sC-2vobA:15.17;5b3sP-2vobA:15.17"],["5CF9_B_NCAB302_0","RIBOSOME-INACTIVATING PROTEIN MOMORDIN I","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"ILE A 598;PHE A 272;ILE A 612;ALA A 596;GLU A 614","None","1.30A","5cf9B-2vobA:undetectable","5cf9B-2vobA:16.24"],["5IY5_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.85A","5iy5C-2vobA:undetectable;5iy5N-2vobA:undetectable;5iy5P-2vobA:undetectable","5iy5C-2vobA:15.22;5iy5N-2vobA:21.23;5iy5P-2vobA:15.22"],["5VEU_A_RITA602_1","CYTOCHROME P450 3A5","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",5,"LEU A 516;PHE A 287;ILE A 529;ALA A 332;GLY A 599","None","0.79A","5veuA-2vobA:undetectable","5veuA-2vobA:21.41"],["5VLM_B_CVIB301_1","REGULATORY PROTEIN TETR","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"GLY A 426;GLN A 321;TRP A 389;ASP A 445","None","1.01A","5vlmB-2vobA:undetectable","5vlmB-2vobA:16.78"],["5W97_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.90A","5w97A-2vobA:undetectable;5w97C-2vobA:undetectable;5w97c-2vobA:undetectable","5w97A-2vobA:21.23;5w97C-2vobA:15.17;5w97c-2vobA:15.17"],["5W97_C_CHDC302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.93A","5w97C-2vobA:undetectable;5w97a-2vobA:undetectable;5w97c-2vobA:undetectable","5w97C-2vobA:15.17;5w97a-2vobA:21.23;5w97c-2vobA:15.17"],["5WAU_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.88A","5wauA-2vobA:undetectable;5wauC-2vobA:undetectable;5wauc-2vobA:undetectable","5wauA-2vobA:21.23;5wauC-2vobA:15.17;5wauc-2vobA:15.17"],["5WAU_C_CHDC303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.85A","5wauC-2vobA:undetectable;5waua-2vobA:undetectable;5wauc-2vobA:undetectable","5wauC-2vobA:15.17;5waua-2vobA:21.23;5wauc-2vobA:15.17"],["5WYQ_A_SAMA401_1","TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 447;SER A 446;ASP A 445;HIS A 399","None","0.90A","5wyqB-2vobA:0.0","5wyqB-2vobA:17.05"],["5X19_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.91A","5x19A-2vobA:undetectable;5x19C-2vobA:undetectable;5x19P-2vobA:undetectable","5x19A-2vobA:21.23;5x19C-2vobA:15.17;5x19P-2vobA:15.17"],["5X1B_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.88A","5x1bA-2vobA:undetectable;5x1bC-2vobA:undetectable;5x1bP-2vobA:undetectable","5x1bA-2vobA:21.23;5x1bC-2vobA:15.17;5x1bP-2vobA:15.17"],["5X1F_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.87A","5x1fA-2vobA:undetectable;5x1fC-2vobA:undetectable;5x1fP-2vobA:undetectable","5x1fA-2vobA:21.23;5x1fC-2vobA:15.17;5x1fP-2vobA:15.17"],["5XDQ_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.89A","5xdqA-2vobA:undetectable;5xdqC-2vobA:undetectable;5xdqP-2vobA:undetectable","5xdqA-2vobA:21.23;5xdqC-2vobA:15.17;5xdqP-2vobA:15.17"],["5XDQ_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.87A","5xdqC-2vobA:undetectable;5xdqN-2vobA:undetectable;5xdqP-2vobA:undetectable","5xdqC-2vobA:15.17;5xdqN-2vobA:21.23;5xdqP-2vobA:15.17"],["5XDX_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.87A","5xdxC-2vobA:undetectable;5xdxN-2vobA:undetectable;5xdxP-2vobA:undetectable","5xdxC-2vobA:14.87;5xdxN-2vobA:21.23;5xdxP-2vobA:14.87"],["5Z84_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.92A","5z84A-2vobA:undetectable;5z84C-2vobA:undetectable;5z84P-2vobA:undetectable","5z84A-2vobA:21.23;5z84C-2vobA:15.17;5z84P-2vobA:15.17"],["5Z84_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.90A","5z84C-2vobA:undetectable;5z84N-2vobA:undetectable;5z84P-2vobA:undetectable","5z84C-2vobA:15.17;5z84N-2vobA:21.23;5z84P-2vobA:15.17"],["5Z85_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.93A","5z85A-2vobA:undetectable;5z85C-2vobA:undetectable;5z85P-2vobA:undetectable","5z85A-2vobA:21.23;5z85C-2vobA:15.17;5z85P-2vobA:15.17"],["5Z85_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.89A","5z85C-2vobA:undetectable;5z85N-2vobA:undetectable;5z85P-2vobA:undetectable","5z85C-2vobA:15.17;5z85N-2vobA:21.23;5z85P-2vobA:15.17"],["5Z86_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.90A","5z86A-2vobA:undetectable;5z86C-2vobA:undetectable;5z86P-2vobA:undetectable","5z86A-2vobA:21.23;5z86C-2vobA:15.17;5z86P-2vobA:15.17"],["5Z86_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.91A","5z86C-2vobA:undetectable;5z86N-2vobA:undetectable;5z86P-2vobA:undetectable","5z86C-2vobA:15.17;5z86N-2vobA:21.23;5z86P-2vobA:15.17"],["5ZCO_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.92A","5zcoA-2vobA:undetectable;5zcoC-2vobA:undetectable;5zcoP-2vobA:undetectable","5zcoA-2vobA:21.23;5zcoC-2vobA:15.17;5zcoP-2vobA:15.17"],["5ZCO_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.90A","5zcoC-2vobA:undetectable;5zcoN-2vobA:undetectable;5zcoP-2vobA:undetectable","5zcoC-2vobA:15.17;5zcoN-2vobA:21.23;5zcoP-2vobA:15.17"],["5ZCP_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.96A","5zcpA-2vobA:undetectable;5zcpC-2vobA:undetectable;5zcpP-2vobA:undetectable","5zcpA-2vobA:21.23;5zcpC-2vobA:15.17;5zcpP-2vobA:15.17"],["5ZCP_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.94A","5zcpC-2vobA:undetectable;5zcpN-2vobA:undetectable;5zcpP-2vobA:undetectable","5zcpC-2vobA:15.17;5zcpN-2vobA:21.23;5zcpP-2vobA:15.17"],["5ZCQ_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.91A","5zcqA-2vobA:undetectable;5zcqC-2vobA:undetectable;5zcqP-2vobA:undetectable","5zcqA-2vobA:21.23;5zcqC-2vobA:15.17;5zcqP-2vobA:15.17"],["6NKN_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"LEU A 493;ASP A 466;THR A 465;TYR A 468","None","0.91A","6nknC-2vobA:undetectable;6nknN-2vobA:undetectable;6nknP-2vobA:undetectable","6nknC-2vobA:15.17;6nknN-2vobA:21.23;6nknP-2vobA:15.17"],["6NMF_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","2vob","TRYPANOTHIONE SYNTHETASE","Leishmania major",4,"ASP A 466;THR A 465;TYR A 468;LEU A 493","None","0.92A","6nmfA-2vobA:undetectable;6nmfC-2vobA:undetectable;6nmfP-2vobA:undetectable","6nmfA-2vobA:21.23;6nmfC-2vobA:15.17;6nmfP-2vobA:15.17"]]